LLS is one of the largest funders of blood cancer research in the world. It provides grants to researchers working on cutting-edge treatments and therapies. The organization also funds clinical trials and collaborates with pharmaceutical companies, academic institutions, and other organizations to accelerate the development of new treatments. Through its Therapy Acceleration Program (TAP), LLS invests directly in companies that are developing promising new therapies.
